Sentence examples for binding in patients with from inspiring English sources

Therefore, PDE10A binding in patients with neuropsychiatric disorders might be modulated by chronic DA-related treatment.

However, we did not find altered hypothalamic SERT binding in patients with hypothalamic impairment.

This study did not show significant differences in the diencephalon/midbrain SERT binding in patients with idiopathic CD compared to controls.

Several studies have detected high PIB binding in patients with posterior cortical atrophy, a visuospatial/biparietal clinical syndrome often caused by AD [ 52- 54].

We found abnormal binding in patients with CBS relative to control subjects, with increased temporal attraction of the perception of action toward a subsequent tone.

Increased temporal lobe alpha activity as a consequence of GABAergic modulation is consistent with the observed reduction in temporal lobe benzodiazepine binding in patients with generalized anxiety disorder [Tiihonen et al., 1997], for which benzodiazepines are a common therapeutic intervention.

In contrast, none of the seven ZnT8A-positive control subjects were positive for any other antibody including ICA, and overall their ZnT8A levels were significantly lower (median [interquartile range]: 1.3% [1.1 1.4] tracer binding) than in patients with solitary ZnT8A positivity (6.7% [2.2 21.3] tracer binding; P < 0.001).

This study is a clinical trial designed to test the reliability and feasibility of sentinel node detection using a new mannose receptor radioactive binding agent in patients with esophageal squamous cell carcinoma.

FP-CIT binding reduction in patients with CBS was characterized by larger variability, more uniform reduction throughout the striatum and greater hemispheric asymmetry compared to PD.

The extension of the PET study of the SPS patient, showing a reduced 11C-FMZ binding potential in limbic structures, supports the concept that the GABAergic system in the amygdala region is affected by the disease, and this is consistent with a significant reduction in GABA-A receptor binding observed in patients with panic disorder and other anxiety-related disorders [14].

Interestingly, ER shows a distinct binding profile in patients with poor clinical outcome to anti-estrogen therapies.